TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · IEX Real-Time Price · USD
89.25
+0.37 (0.42%)
At close: Apr 25, 2024, 4:00 PM
88.00
-1.25 (-1.40%)
After-hours: Apr 25, 2024, 6:57 PM EDT

TransMedics Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Net Income
-25.03-36.23-44.22-28.75-33.55-23.76-20.82-24.07
Depreciation & Amortization
9.224.22.651.581.220.770.630.43
Share-Based Compensation
19.7910.326.882.410.850.140.070.05
Other Operating Activities
-17.01-24.15.83-5.51-0.82-3.14-2.98-0.52
Operating Cash Flow
-13.03-45.82-28.86-30.27-32.29-25.98-23.1-24.11
Capital Expenditures
-151.85-11.91-3.52-0.46-0.17-0.42-0.26-1.48
Acquisitions
-42.110000000
Change in Investments
066.4232.79-41.14-60.3412.7325.12-38.19
Investing Cash Flow
-193.9554.5129.27-41.6-60.512.3124.86-39.67
Share Issuance / Repurchase
7.11145.471.3975.5597.570.0500.02
Debt Issued / Paid
393.3122.4600024.360-0.09
Other Financing Activities
-----4.85-2.34-63.61
Financing Cash Flow
400.42167.931.3975.5592.7222.06063.54
Exchange Rate Effect
0.19-1.02-0.80.8-0.09-0.080.34-0.01
Net Cash Flow
193.63175.614.49-0.158.312.1-0.24
Free Cash Flow
-164.88-57.72-32.38-30.72-32.45-26.4-23.36-25.59
Free Cash Flow Margin
-68.24%-61.76%-107.01%-119.82%-137.48%-202.83%-303.98%-412.10%
Free Cash Flow Per Share
-5.07-1.95-1.17-1.24-2.29-19.43-5.03-5.68
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).